These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11557684)

  • 1. Characterization of a mouse model for thrombomodulin deficiency.
    Weiler H; Lindner V; Kerlin B; Isermann BH; Hendrickson SB; Cooley BC; Meh DA; Mosesson MW; Shworak NW; Post MJ; Conway EM; Ulfman LH; von Andrian UH; Weitz JI
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1531-7. PubMed ID: 11557684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis.
    Dörffler-Melly J; de Kruif M; Schwarte LA; Franco RF; Florquin S; Spek CA; Ince C; Reitsma PH; ten Cate H
    Basic Res Cardiol; 2003 Nov; 98(6):347-52. PubMed ID: 14556079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis.
    Isermann B; Hendrickson SB; Zogg M; Wing M; Cummiskey M; Kisanuki YY; Yanagisawa M; Weiler H
    J Clin Invest; 2001 Aug; 108(4):537-46. PubMed ID: 11518727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis.
    Vicente CP; Weiler H; Di Cera E; Tollefsen DM
    Thromb Res; 2012 Oct; 130(4):646-8. PubMed ID: 22178578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide.
    Rijneveld AW; Weijer S; Florquin S; Esmon CT; Meijers JC; Speelman P; Reitsma PH; Ten Cate H; van der Poll T
    Blood; 2004 Mar; 103(5):1702-9. PubMed ID: 14592828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition.
    Maroney SA; Cooley BC; Sood R; Weiler H; Mast AE
    J Thromb Haemost; 2008 Jan; 6(1):111-7. PubMed ID: 17973652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of thrombosis: thrombomodulin.
    Weiler H
    Thromb Haemost; 2004 Sep; 92(3):467-77. PubMed ID: 15351842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.
    Ding BS; Hong N; Christofidou-Solomidou M; Gottstein C; Albelda SM; Cines DB; Fisher AB; Muzykantov VR
    Am J Respir Crit Care Med; 2009 Aug; 180(3):247-56. PubMed ID: 19342415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin.
    Starr ME; Ueda J; Takahashi H; Weiler H; Esmon CT; Evers BM; Saito H
    Blood; 2010 Jun; 115(23):4886-93. PubMed ID: 20348393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model.
    Li YH; Liu SL; Shi GY; Tseng GH; Liu PY; Wu HL
    Thromb Haemost; 2006 Jan; 95(1):128-33. PubMed ID: 16543971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.
    Weiler-Guettler H; Christie PD; Beeler DL; Healy AM; Hancock WW; Rayburn H; Edelberg JM; Rosenberg RD
    J Clin Invest; 1998 May; 101(9):1983-91. PubMed ID: 9576763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.
    Carnemolla R; Greineder CF; Chacko AM; Patel KR; Ding BS; Zaitsev S; Esmon CT; Muzykantov VR
    J Pharmacol Exp Ther; 2013 Nov; 347(2):339-45. PubMed ID: 23965383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
    Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
    Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.
    Keller TT; van der Sluijs KF; de Kruif MD; Gerdes VE; Meijers JC; Florquin S; van der Poll T; van Gorp EC; Brandjes DP; Büller HR; Levi M
    Circ Res; 2006 Nov; 99(11):1261-9. PubMed ID: 17068293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis.
    Dayal S; Gu SX; Hutchins RD; Wilson KM; Wang Y; Fu X; Lentz SR
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1798-804. PubMed ID: 26069236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide augments venous and arterial thrombosis in the mouse.
    Wang X
    Thromb Res; 2008; 123(2):355-60. PubMed ID: 18448153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice.
    Hansen HR; Wolfs JL; Bruggemann L; Sommeijer DW; Bevers E; Hauer AD; Kuiper J; Spek CA; Spronk HM; Reitsma PH; ten Cate H
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):627-36. PubMed ID: 17890950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.
    Conway EM; Van de Wouwer M; Pollefeyt S; Jurk K; Van Aken H; De Vriese A; Weitz JI; Weiler H; Hellings PW; Schaeffer P; Herbert JM; Collen D; Theilmeier G
    J Exp Med; 2002 Sep; 196(5):565-77. PubMed ID: 12208873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 modulates thrombomodulin and activated protein C levels to attenuate lung injury in cecal ligation and puncture-induced acute lung injury mice.
    Fei D; Meng X; Kang K; Nan C; Zhao M; Pan S; Gao M; Yang S; Zhao M
    Exp Lung Res; 2012 May; 38(4):173-82. PubMed ID: 22417130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.